ICG has held the final close of the ICG Strategic Equity IV fund, which is focused on GP-led secondaries, at over $5bn in capital commitments, according to a report by Secondaries Investor.
The report cites unnamed sources as revealing that the fund reached final close after just 18 months in the market having been launched in November 2020.
ICG chief investment officer and chief executive officer Benoît Durteste is reported as previously saying during the firm’s annual results presentation in May that the final close would be held within the coming financial year.
Get the week’s top news delivered directly to your inbox – Sign up for our newsletter
SE IV is backed by investors including CalPERS – the California Public Employees’ Retirement System ($250m), Fubon Life Insurance ($65m), and the New York City Employees’ Retirement System, are among the fund’s backers.
ICG IV’s predecessor fund held its final close in January 2020 at $2.4bn.
This latest fundraising brings ICG’s total capital under management to over $40bn.
Source: Private Equity Wire
Can’t stop reading? Read more
TPG explores $7.5bn Asia OneHealthcare exit with sale or IPO options
TPG explores $7.5bn Asia OneHealthcare exit with sale or IPO options TPG has appointed Malayan...
Blackstone teams with Dubai Aerospace on $1.6bn annual aircraft leasing push
Blackstone teams with Dubai Aerospace on $1.6bn annual aircraft leasing push Blackstone has...
CVC seeks co-investors for $12.7bn Recordati buyout in mega LBO push
CVC seeks co-investors for $12.7bn Recordati buyout in mega LBO push CVC Capital Partners is...




